Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

Hermann Herbst, Friederike Dallenbach, Michael Hummel, Gerald Niedobitek, Stefano Pileri, Nikolaus Müller-Lantzsch, Harald Stein

Research output: Contribution to journalArticle

324 Citations (Scopus)

Abstract

Cryostat sections from lymph nodes of 47 Hodgkin disease patients were examined by immunohistology for the Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP), nuclear antigen 2, and late viral glycoprotein gp350/250. A distinct LMP-specific membrane and cytoplasmic staining was detected exclusively in Hodgkin and Reed-Sternberg cells in 18 patients (38%); EBV nuclear antigen 2 and gp350/250 immunoreactivity was absent in all instances. Thirty-two of 47 (68%) cases contained EBV-speciflc DNA sequences as detected by PCR, all LMP-positive cases being in this category. Our results confirm previous studies establishing the presence of EBV genomes in Hodgkin and Reed-Sternberg cells by demonstrating expression of an EBV-encoded protein in the tumor-cell population. The finding of LMP expression in the absence of EBV nuclear antigen 2 suggests a pattern of EBV gene expression different from that of B-lymphoblastoid cell lines and Burkitt lymphoma, whereas this finding shows similarities with that seen in undifferentiated nasopharyngeal carcinoma. Because the LMP gene has transforming potential, our findings support the concept of a pathoetiological role of EBV in many cases of Hodgkin disease.

Original languageEnglish
Pages (from-to)4766-4770
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume88
Issue number11
Publication statusPublished - Jun 1 1991

Fingerprint

Reed-Sternberg Cells
Human Herpesvirus 4
Hodgkin Disease
Membrane Proteins
Epstein-Barr Virus Nuclear Antigens
Nuclear Antigens
Burkitt Lymphoma
Oncogenes
Glycoproteins
Lymph Nodes
Cell Membrane
Genome
Staining and Labeling
Carcinoma
Gene Expression
Cell Line
Polymerase Chain Reaction
Population
Neoplasms

Keywords

  • Hodgkin disease
  • Immunohistology
  • Malignant lymphomas
  • Oncogenes
  • PCR

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Herbst, H., Dallenbach, F., Hummel, M., Niedobitek, G., Pileri, S., Müller-Lantzsch, N., & Stein, H. (1991). Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proceedings of the National Academy of Sciences of the United States of America, 88(11), 4766-4770.

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. / Herbst, Hermann; Dallenbach, Friederike; Hummel, Michael; Niedobitek, Gerald; Pileri, Stefano; Müller-Lantzsch, Nikolaus; Stein, Harald.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, No. 11, 01.06.1991, p. 4766-4770.

Research output: Contribution to journalArticle

Herbst, H, Dallenbach, F, Hummel, M, Niedobitek, G, Pileri, S, Müller-Lantzsch, N & Stein, H 1991, 'Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells', Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 11, pp. 4766-4770.
Herbst, Hermann ; Dallenbach, Friederike ; Hummel, Michael ; Niedobitek, Gerald ; Pileri, Stefano ; Müller-Lantzsch, Nikolaus ; Stein, Harald. / Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. In: Proceedings of the National Academy of Sciences of the United States of America. 1991 ; Vol. 88, No. 11. pp. 4766-4770.
@article{04286665cbeb4e50b7f5de645b2eb055,
title = "Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells",
abstract = "Cryostat sections from lymph nodes of 47 Hodgkin disease patients were examined by immunohistology for the Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP), nuclear antigen 2, and late viral glycoprotein gp350/250. A distinct LMP-specific membrane and cytoplasmic staining was detected exclusively in Hodgkin and Reed-Sternberg cells in 18 patients (38{\%}); EBV nuclear antigen 2 and gp350/250 immunoreactivity was absent in all instances. Thirty-two of 47 (68{\%}) cases contained EBV-speciflc DNA sequences as detected by PCR, all LMP-positive cases being in this category. Our results confirm previous studies establishing the presence of EBV genomes in Hodgkin and Reed-Sternberg cells by demonstrating expression of an EBV-encoded protein in the tumor-cell population. The finding of LMP expression in the absence of EBV nuclear antigen 2 suggests a pattern of EBV gene expression different from that of B-lymphoblastoid cell lines and Burkitt lymphoma, whereas this finding shows similarities with that seen in undifferentiated nasopharyngeal carcinoma. Because the LMP gene has transforming potential, our findings support the concept of a pathoetiological role of EBV in many cases of Hodgkin disease.",
keywords = "Hodgkin disease, Immunohistology, Malignant lymphomas, Oncogenes, PCR",
author = "Hermann Herbst and Friederike Dallenbach and Michael Hummel and Gerald Niedobitek and Stefano Pileri and Nikolaus M{\"u}ller-Lantzsch and Harald Stein",
year = "1991",
month = "6",
day = "1",
language = "English",
volume = "88",
pages = "4766--4770",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "11",

}

TY - JOUR

T1 - Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

AU - Herbst, Hermann

AU - Dallenbach, Friederike

AU - Hummel, Michael

AU - Niedobitek, Gerald

AU - Pileri, Stefano

AU - Müller-Lantzsch, Nikolaus

AU - Stein, Harald

PY - 1991/6/1

Y1 - 1991/6/1

N2 - Cryostat sections from lymph nodes of 47 Hodgkin disease patients were examined by immunohistology for the Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP), nuclear antigen 2, and late viral glycoprotein gp350/250. A distinct LMP-specific membrane and cytoplasmic staining was detected exclusively in Hodgkin and Reed-Sternberg cells in 18 patients (38%); EBV nuclear antigen 2 and gp350/250 immunoreactivity was absent in all instances. Thirty-two of 47 (68%) cases contained EBV-speciflc DNA sequences as detected by PCR, all LMP-positive cases being in this category. Our results confirm previous studies establishing the presence of EBV genomes in Hodgkin and Reed-Sternberg cells by demonstrating expression of an EBV-encoded protein in the tumor-cell population. The finding of LMP expression in the absence of EBV nuclear antigen 2 suggests a pattern of EBV gene expression different from that of B-lymphoblastoid cell lines and Burkitt lymphoma, whereas this finding shows similarities with that seen in undifferentiated nasopharyngeal carcinoma. Because the LMP gene has transforming potential, our findings support the concept of a pathoetiological role of EBV in many cases of Hodgkin disease.

AB - Cryostat sections from lymph nodes of 47 Hodgkin disease patients were examined by immunohistology for the Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP), nuclear antigen 2, and late viral glycoprotein gp350/250. A distinct LMP-specific membrane and cytoplasmic staining was detected exclusively in Hodgkin and Reed-Sternberg cells in 18 patients (38%); EBV nuclear antigen 2 and gp350/250 immunoreactivity was absent in all instances. Thirty-two of 47 (68%) cases contained EBV-speciflc DNA sequences as detected by PCR, all LMP-positive cases being in this category. Our results confirm previous studies establishing the presence of EBV genomes in Hodgkin and Reed-Sternberg cells by demonstrating expression of an EBV-encoded protein in the tumor-cell population. The finding of LMP expression in the absence of EBV nuclear antigen 2 suggests a pattern of EBV gene expression different from that of B-lymphoblastoid cell lines and Burkitt lymphoma, whereas this finding shows similarities with that seen in undifferentiated nasopharyngeal carcinoma. Because the LMP gene has transforming potential, our findings support the concept of a pathoetiological role of EBV in many cases of Hodgkin disease.

KW - Hodgkin disease

KW - Immunohistology

KW - Malignant lymphomas

KW - Oncogenes

KW - PCR

UR - http://www.scopus.com/inward/record.url?scp=0025819202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025819202&partnerID=8YFLogxK

M3 - Article

VL - 88

SP - 4766

EP - 4770

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 11

ER -